RNA viruses are among the most significant pathogens affecting human health, responsible for diseases ranging from the common cold to severe acute respiratory syndromes. Similarly, DNA viruses, including those used in vaccine development and cancer therapies, play crucial roles in human disease and therapeutic interventions. Understanding the intricate interactions between RNA and DNA viruses and host factors is essential for developing effective therapeutic strategies. This special issue aims to explore the diverse mechanisms through which RNA and DNA viruses manipulate host cellular machinery and evade immune responses.
The primary goal of this Research Topic is to address the challenges and opportunities in studying virus-host interactions and viral immune responses. We aim to gather recent advances in the field, highlight novel methodologies, and promote a deeper understanding of the molecular and cellular mechanisms underlying these interactions. This collection will provide a platform for researchers to share insights and propose innovative solutions to combat viral infections, encompassing both RNA and DNA viruses.
We invite researchers to submit original research articles, reviews, and perspectives on the following themes:
• Mechanisms of RNA and DNA virus entry, replication, and assembly in host cells
• Host cellular factors influencing RNA and DNA viruses life cycles
• Immune evasion strategies employed by RNA and DNA viruses
• Host immune response to RNA and DNA viruses infections
• Development of antiviral therapies targeting virus-host interactions
• Use of DNA viruses in vaccine development and cancer therapies
• Advanced techniques, such as high-throughput sequencing, CRISPR-Cas systems, and single-cell analysis to unravel the complexities of virus-host interactions
Note that Dr Zhenlong Liu has a CO-PI research position at Lady Davis Institute, McGill University. He is also CEO & cofounder of Ebovir Biotechnologie Inc, which is not related to this research topic.
Keywords:
RNA viruses, Host-pathogen interactions, Immune evasion, Antiviral therapies, Virus-host interactions, DNA viruses
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
RNA viruses are among the most significant pathogens affecting human health, responsible for diseases ranging from the common cold to severe acute respiratory syndromes. Similarly, DNA viruses, including those used in vaccine development and cancer therapies, play crucial roles in human disease and therapeutic interventions. Understanding the intricate interactions between RNA and DNA viruses and host factors is essential for developing effective therapeutic strategies. This special issue aims to explore the diverse mechanisms through which RNA and DNA viruses manipulate host cellular machinery and evade immune responses.
The primary goal of this Research Topic is to address the challenges and opportunities in studying virus-host interactions and viral immune responses. We aim to gather recent advances in the field, highlight novel methodologies, and promote a deeper understanding of the molecular and cellular mechanisms underlying these interactions. This collection will provide a platform for researchers to share insights and propose innovative solutions to combat viral infections, encompassing both RNA and DNA viruses.
We invite researchers to submit original research articles, reviews, and perspectives on the following themes:
• Mechanisms of RNA and DNA virus entry, replication, and assembly in host cells
• Host cellular factors influencing RNA and DNA viruses life cycles
• Immune evasion strategies employed by RNA and DNA viruses
• Host immune response to RNA and DNA viruses infections
• Development of antiviral therapies targeting virus-host interactions
• Use of DNA viruses in vaccine development and cancer therapies
• Advanced techniques, such as high-throughput sequencing, CRISPR-Cas systems, and single-cell analysis to unravel the complexities of virus-host interactions
Note that Dr Zhenlong Liu has a CO-PI research position at Lady Davis Institute, McGill University. He is also CEO & cofounder of Ebovir Biotechnologie Inc, which is not related to this research topic.
Keywords:
RNA viruses, Host-pathogen interactions, Immune evasion, Antiviral therapies, Virus-host interactions, DNA viruses
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.